Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-01-09 @ 1:40 AM
Study NCT ID:
NCT04620733
Status:
COMPLETED
Last Update Posted:
2024-09-05
First Post:
2020-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-04
First Submit QC Date:
None
Study First Post Date:
2020-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-01
Results First Submit QC Date:
None
Results First Post Date:
2024-07-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-09-29
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-08-13
Last Update Post Date:
2024-09-05
Last Update Post Date Type:
ACTUAL